PT68317A - Procede pour la preparation de nouveaux composes organiques effet pharmaceutique - Google Patents

Procede pour la preparation de nouveaux composes organiques effet pharmaceutique

Info

Publication number
PT68317A
PT68317A PT68317A PT6831778A PT68317A PT 68317 A PT68317 A PT 68317A PT 68317 A PT68317 A PT 68317A PT 6831778 A PT6831778 A PT 6831778A PT 68317 A PT68317 A PT 68317A
Authority
PT
Portugal
Prior art keywords
preparation
organic compounds
new organic
pharmaceutical effect
compounds pharmaceutical
Prior art date
Application number
PT68317A
Other languages
English (en)
French (fr)
Portuguese (pt)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH907777A external-priority patent/CH632246A5/de
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT68317A publication Critical patent/PT68317A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT68317A 1977-07-21 1978-07-19 Procede pour la preparation de nouveaux composes organiques effet pharmaceutique PT68317A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH907777A CH632246A5 (en) 1977-07-21 1977-07-21 Process for preparing novel 3-aminopropoxyindoles
CH907377 1977-07-21
CH906577 1977-07-21
CH907077 1977-07-21

Publications (1)

Publication Number Publication Date
PT68317A true PT68317A (fr) 1978-08-01

Family

ID=27429188

Family Applications (1)

Application Number Title Priority Date Filing Date
PT68317A PT68317A (fr) 1977-07-21 1978-07-19 Procede pour la preparation de nouveaux composes organiques effet pharmaceutique

Country Status (18)

Country Link
JP (1) JPS5422364A (xx)
AU (1) AU523105B2 (xx)
BE (1) BE869133A (xx)
CA (1) CA1098909A (xx)
DE (1) DE2830211A1 (xx)
DK (1) DK312878A (xx)
ES (1) ES471863A1 (xx)
FI (1) FI782229A (xx)
FR (1) FR2398058A1 (xx)
GB (1) GB2001971B (xx)
IE (1) IE47131B1 (xx)
IL (1) IL55170A (xx)
IT (1) IT1105092B (xx)
NL (1) NL7807626A (xx)
NZ (1) NZ187909A (xx)
PT (1) PT68317A (xx)
SE (1) SE435374B (xx)
SU (1) SU843740A3 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0025111B1 (en) * 1979-08-10 1984-07-25 Sandoz Ag 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
DE3030047A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
BR9708632A (pt) 1996-04-09 2000-01-18 Nps Pharma Inc Composto calcilìticos
ES2171839T3 (es) * 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
AU1580001A (en) * 1999-11-15 2001-05-30 Eli Lilly And Company Process for the preparation of aryloxy propanolamines
AU2017263657A1 (en) 2016-05-13 2018-11-29 The Board Of Trustees Of The Leland Stanford Junior University Adrenergic receptor modulating compounds and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1547056A (fr) * 1966-12-13 1968-11-22 Sandoz Sa Dérivés de l'indole et leur préparation
FR2019185A1 (en) * 1968-09-30 1970-06-26 Sandoz Sa 4-(2-hydroxy-3-amino-propoxy)-indole-2-carboxy- - lic acids and esters and 2-hydroxymethylindoles as beta
US3699123A (en) * 1970-03-24 1972-10-17 Sandoz Ltd 4-(3-amino-2-hydroxy-propoxy) indole derivatives
US4076829A (en) * 1974-11-16 1978-02-28 Boehringer Mannheim Gmbh Aminopropanol compounds and compositions for the treatment of cardiac and circulatory diseases
DE2508251C2 (de) * 1975-02-26 1983-12-29 Boehringer Mannheim Gmbh, 6800 Mannheim Derivate des Indols, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
DE2633839A1 (de) * 1975-08-07 1977-02-24 Sandoz Ag Neue 4-aminopropoxyindolderivate, ihre herstellung und verwendung
DE2635209C2 (de) * 1975-08-15 1983-01-27 Sandoz-Patent-GmbH, 7850 Lörrach 4-(2-Benzoyloxy-3-tert.butylamino-propoxy)-2-methylindol, dessen (S)-Enantiomeres, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Heilmittel

Also Published As

Publication number Publication date
IE781448L (en) 1979-01-21
AU523105B2 (en) 1982-07-15
SU843740A3 (ru) 1981-06-30
JPS5422364A (en) 1979-02-20
GB2001971A (en) 1979-02-14
IL55170A0 (en) 1978-09-29
FI782229A (fi) 1979-01-22
FR2398058B1 (xx) 1982-08-06
AU3818278A (en) 1980-01-24
NZ187909A (en) 1981-04-24
FR2398058A1 (fr) 1979-02-16
BE869133A (fr) 1979-01-19
SE7807753L (sv) 1979-01-22
IL55170A (en) 1982-07-30
NL7807626A (nl) 1979-01-23
IE47131B1 (en) 1983-12-28
IT7850299A0 (it) 1978-07-14
ES471863A1 (es) 1979-10-01
IT1105092B (it) 1985-10-28
DE2830211A1 (de) 1979-02-01
CA1098909A (en) 1981-04-07
GB2001971B (en) 1982-02-10
DK312878A (da) 1979-01-22
SE435374B (sv) 1984-09-24

Similar Documents

Publication Publication Date Title
PT68013B (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT68707A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT66475A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT68191A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT68317A (fr) Procede pour la preparation de nouveaux composes organiques effet pharmaceutique
PT68722A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT66800A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT66137A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT70601A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT65436A (fr) Procede pour la preparation de nouveaux composes organiques en effet pharmaceutique
PT65477A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT69740A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT64942A (fr) Procede pour la preparation nouveaux composes organiques en effet pharmaceutique
PT67084A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT69019A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT69536A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT67816A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT66238B (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT67058A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT69097A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT65553A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT68522A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique.
PT67807A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT68491A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique
PT66873A (fr) Procede pour la preparation de nouveaux composes organiques a effet pharmaceutique